Kathleen Liu United States

Kathleen Liu
Kathleen Liu is Professor of Medicine and Anesthesia in the Divisions of Nephrology and Critical Care Medicine and the Medical Director of the Medical Intensive Care Unit and the Apheresis/Hemodialysis Unit at the University of California, San Francisco. Her research has focused on acute kidney injury and the acute respiratory distress syndrome, with an emphasis on biomarkers and clinical trials. Dr. Liu is the current external steering committee chair for the NIDDK-funded Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) study. Dr. Liu chairs the American Society of Nephrology Kidney Health Guidance Oversight Committee and is a member of the ASN AKI!Now Steering Committee.

19th September 2026 Saturday

Time Session
07:30
08:15
Meet the Expert 1
How do I Manage Patients with Acute Liver Failure
Chieh-Hsin Huang Moderator
  • How do I Manage Patients with Acute Liver Failure
    Kathleen Liu Speaker How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow do I care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices
    Mitra Nadim Speaker Hepatorenal Syndrome: Recognition and Management or Disordered Physiology or Iatrogenic FailureManaging Patients With Combined Kidney and Liver FailureHow do I Manage Patients with Combined Kidney and Liver Failure
Room 1
08:30
10:15
Plenary 1: Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
Chih-Wei Yang Moderator
Room 1
14:00
15:30
Workshop 1 - Session D
How Do I Care for the Patient with ARDS and AKI
  • How Do I Care for the Patient with ARDS and AKI
    Kathleen Liu Speaker How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow do I care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices
    Keith Wille Speaker Connectology with Hybrid Systems: ECMO, Apheresis, ECCO2RAKI in the Mechanical Circulatory SupportHow do I care for the Patient with ARDS and AKI
    Chien-Liang Chen Moderator
    Chien-Yu Lin Moderator
Room 4

20th September 2026 Sunday

Time Session
08:30
10:15
Plenary 4: Challenges and Controversies in Renal Support and CRRT
Kuang-Yao Yang Moderator
  • AI in the ICU or Chat GPT Applications in Critical Care Nephrology
    Kianoush Kashani Speaker Practical Steps to Train (and Become) an AI-Era PhysicianAI in Critical Care Nephrology — State of the Art and the Path from Algorithm to BedsideLate breaking clinical trials or Critical Care Nephrology: Literature Review AI in the ICU or Chat GPT Applications in Critical Care Nephrology
  • Fluid Balance Reimagined: Hemodynamic Monitoring and Ultrafiltration Precision
    Ravindra Mehta Speaker
  • Precision Volume Management in CRRT: Insights from Bioimpedance and Biomarkers
    Sejoong Kim Speaker Korean Big-Data Experience in AKI and CRRT OutcomesSouth Korea has established a robust nationwide health data infrastructure, enabling large-scale analyses of acute kidney injury (AKI) and continuous renal replacement therapy (CRRT). Leveraging the Health Insurance Review and Assessment Service (HIRA) and National Health Insurance Service (NHIS) databases, Korean researchers have characterized AKI incidence, risk factors, and short- and long-term outcomes across diverse clinical settings. Studies utilizing CRRT data have identified predictors of mortality, renal recovery, and progression to chronic kidney disease. These big-data approaches provide critical real-world evidence, informing clinical practice and guiding future interventional strategies in critically ill patients with AKI.Precision Volume Management in CRRT: Insights from Bioimpedance and BiomarkersOptimal fluid balance is critical in critically ill patients undergoing continuous renal replacement therapy (CRRT), yet accurate volume assessment remains challenging. Bioimpedance analysis (BIA) offers a non-invasive, objective method to quantify fluid overload and guide individualized ultrafiltration targets. Complementing BIA, emerging biomarkers provide dynamic, real-time insights into volume status and end-organ perfusion. Integrating these tools into a precision medicine framework may optimize fluid removal strategies, reduce complications, and improve survival outcomes in CRRT-dependent patients. Prospective validation of this combined approach is warranted.
  • Dynamic Prescription of CRRT Ready for Prime Time
    John Prowle Speaker Trajectories of Critical Illness – Defining Endotypes from Routine DataDynamic Prescription of CRRT Ready for Prime TimeAdapting CRRT for patients with Electrolyte and acid-base disordersExtracorporeal Therapies in Trauma, Burns and Cerebral Edema
  • Bicarbonate in AKI: Use and Misuse
    Lui Forni Speaker Sepsis Associated AKIBicarbonate therapy for AKI or Bicarbonate in AKI: Use and MisuseAdapting CRRT for Patients with Electrolyte and Acid-Base Disorders
  • De-escalating and Transitioning RRT: Best Practices
    Kathleen Liu Speaker How do I Manage Patients with Combined Kidney and Liver FailureKidney-Ventilator Interactions and Kidney Protective Ventilation /or Lung and Kidney CrosstalkHow do I care for the Patient with ARDS and AKIDe-escalating and Transitioning RRT: Best Practices
  • Q & A
Room 1